Medical Properties Trust (NYSE:MPW – Get Rating) had its target price raised by equities researchers at Truist Financial from $8.00 to $9.00 in a research note issued on Friday, The Fly reports. Truist Financial’s price objective points to a potential upside of 11.94% from the company’s previous close.
→ Sell every Stock except ONE (From Legacy Research)
A number of other equities research analysts have also recently issued reports on the stock. JPMorgan Chase & Co. dropped their target price on shares of Medical Properties Trust from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Friday, March 3rd. Barclays lowered their price target on shares of Medical Properties Trust from $17.00 to $14.00 and set an “overweight” rating on the stock in a report on Monday, February 27th. StockNews.com began coverage on shares of Medical Properties Trust in a report on Thursday, March 16th. They issued a “hold” rating on the stock. Credit Suisse Group reissued a “neutral” rating and issued a $11.00 price target on shares of Medical Properties Trust in a report on Tuesday, March 7th. Finally, Bank of America cut shares of Medical Properties Trust from a “buy” rating to a “neutral” rating and set a $10.00 price target on the stock. in a report on Thursday, March 16th. Seven analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, Medical Properties Trust has a consensus rating of “Hold” and an average target price of $14.00.
Medical Properties Trust Stock Up 4.6 %
Shares of MPW stock opened at $8.04 on Friday. The company has a debt-to-equity ratio of 1.19, a quick ratio of 1.92 and a current ratio of 1.92. The firm’s 50-day moving average is $10.75 and its 200-day moving average is $11.56. The stock has a market cap of $4.81 billion, a price-to-earnings ratio of 5.36, a PEG ratio of 0.45 and a beta of 0.96. Medical Properties Trust has a 52-week low of $7.10 and a 52-week high of $21.63.
Institutional Trading of Medical Properties Trust
Large investors have recently made changes to their positions in the company. Janney Montgomery Scott LLC boosted its position in shares of Medical Properties Trust by 8.9% during the 3rd quarter. Janney Montgomery Scott LLC now owns 471,278 shares of the real estate investment trust’s stock worth $5,589,000 after acquiring an additional 38,408 shares in the last quarter. United Services Automobile Association lifted its stake in Medical Properties Trust by 3.0% in the 3rd quarter. United Services Automobile Association now owns 65,728 shares of the real estate investment trust’s stock valued at $779,000 after purchasing an additional 1,884 shares during the last quarter. Mutual Advisors LLC lifted its stake in Medical Properties Trust by 13.0% in the 2nd quarter. Mutual Advisors LLC now owns 83,430 shares of the real estate investment trust’s stock valued at $1,274,000 after purchasing an additional 9,630 shares during the last quarter. Pallas Capital Advisors LLC lifted its stake in Medical Properties Trust by 8.8% in the 3rd quarter. Pallas Capital Advisors LLC now owns 129,099 shares of the real estate investment trust’s stock valued at $1,433,000 after purchasing an additional 10,463 shares during the last quarter. Finally, Capital Investment Advisors LLC lifted its stake in Medical Properties Trust by 26.0% in the 4th quarter. Capital Investment Advisors LLC now owns 578,808 shares of the real estate investment trust’s stock valued at $6,448,000 after purchasing an additional 119,350 shares during the last quarter. Institutional investors and hedge funds own 80.31% of the company’s stock.
About Medical Properties Trust
Medical Properties Trust, Inc is a self-advised real estate investment trust, engages in the investment, acquisition, and development of net-leased healthcare facilities. Its property portfolio includes rehabilitation hospitals, long-term acute care hospitals, ambulatory surgery centers, hospitals for women and children, regional and community hospitals, medical office buildings, and other single-discipline facilities.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Medical Properties Trust, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Medical Properties Trust wasn’t on the list.
While Medical Properties Trust currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Source: marketbeat.com
